Document is current
Any future updates will be listed below
-
Authors
Haukeland-Parker, Stacey
Jervan, Øyvind
Johannessen, Hege Hølmo
Gleditsch, Jostein
Stavem, Knut
Steine, Kjetil
Spruit, Martijn A.
Holst, René
Tavoly, Mazdak
Klok, Frederikus A.
Ghanima, Waleed
-
Funding
Funding for this research was provided by:
Sykehuset Østfold (15/00601-56)
- License Information
-
More Information
Article History
Received: 30 April 2020
Accepted: 30 November 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: The choice of the study design and methods are based on a solid rationale and international recommendations. Patients will be informed about the study including the design, examinations, intervention, and anticipated benefits. Written informed consent will be obtained from all participants prior to clinical procedures. Patients will be enrolled by the PhD candidates, and written informed consent will be gathered at the first appointment at baseline. Patients who decline participation will be managed according to the best current practice. The study is registered in Clinical Trials (NCT03405480). The protocol, including the patient information and consent form, is approved by the Regional Committee for Medical and Health Research Ethics (2017/1940/REK South-East D). See . New ethical approval will be applied for in the case of additional data collection that was not specified on the original application.
: Not applicable.
: The authors declare that they have no competing interests.
